Trial Profile

Comparison of Methotrexate Versus Interferon-alfa 2b on Efficacy, Safety and Quality of Life in Patients With Primary Cutaneous T-cell Lymphomas

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon alpha-2b (Primary) ; Methotrexate (Primary)
Indications Cutaneous T-cell lymphoma
Focus Therapeutic Use

Most Recent Events

23 Dec 2021 Status changed from recruiting to discontinued. Reason the study was stopped: Slow recruitment.
12 Jul 2017 Planned End Date changed from 1 May 2017 to 1 Dec 2017.
12 Jul 2017 Planned primary completion date changed from 1 May 2017 to 1 Dec 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com